Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
Cash Flow from Operations
USD -221.7 Mil (TTM As of Dec. 2015)

Cash flow from operations refers to the cash brought in through a company’'s normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Dec. 2015, Biomarin Pharmaceutical Inc's Net Income From Continuing Operations was USD 68.6 Mil. Its DDA was USD 1.9 Mil. Its Change In Working Capital was USD 135.8 Mil. Its cash flow from deferred tax was USD -91.5 Mil. Its Cash Flow from Discontinued Operations was USD 0.0 Mil. Its Stock Based Compensation was USD 27.1 Mil. And its Cash Flow from Others was USD -210.0 Mil. In all, Biomarin Pharmaceutical Inc's Cash Flow from Operations for the three months ended in Dec. 2015 was USD -68.0 Mil.


Definition

Cash flow from operations refers to the cash brought in through a company’'s normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Biomarin Pharmaceutical Inc's Cash Flow from Operations for the fiscal year that ended in Dec. 2015 is calculated as:

Biomarin Pharmaceutical Inc's Cash Flow from Operations for the quarter that ended in Dec. 2015 is

Biomarin Pharmaceutical Inc Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2015 was -137.811 (Mar. 2015 ) + -12.991 (Jun. 2015 ) + -2.85 (Sep. 2015 ) + -68.037 (Dec. 2015 ) = USD -221.7 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Biomarin Pharmaceutical Inc's net income from continuing operations for the three months ended in Dec. 2015 was USD 68.6 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
• The term “depreciation” is used when discussing man made tangible assets
• The term “depletion” is used when discussing natural tangible assets
• The term “amortization” is used when discussing intangible assets

Biomarin Pharmaceutical Inc's depreciation, depletion and amortization for the three months ended in Dec. 2015 was USD 1.9 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Biomarin Pharmaceutical Inc's change in working capital for the three months ended in Dec. 2015 was USD 135.8 Mil. It means Biomarin Pharmaceutical Inc's working capital increased by USD 135.8 Mil from Sep. 2015 to Dec. 2015 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Biomarin Pharmaceutical Inc's cash flow from deferred tax for the three months ended in Dec. 2015 was USD -91.5 Mil.

5. Cash Flow from Discontinued Operations:
Cash received by a company that comes from the sale of part of business.

Biomarin Pharmaceutical Inc's cash flow from discontinued operations for the three months ended in Dec. 2015 was USD 0.0 Mil.

6. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Biomarin Pharmaceutical Inc's stock based compensation for the three months ended in Dec. 2015 was USD 27.1 Mil.

7. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Biomarin Pharmaceutical Inc's cash flow from others for the three months ended in Dec. 2015 was USD -210.0 Mil.


Related Terms

Net Income From Continuing Operations, Depreciation, Depletion and Amortization, Change In Working Capital, Cash Flow from Discontinued Operations, Stock Based Compensation, Cash Flow from Others, Cash Flow from Investing


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
NetIncomeFromContinuingOperations -28.5-15.830.8-0.5205.8-53.8-114.3-176.4-134.0-171.8
CF_DDA 12.01.117.621.027.736.145.347.356.747.2
ChangeInWorkingCapital -29.5-13.2-89.019.9-42.1-25.133.1-23.1-30.346.3
CF_DeferredTax 0.00.00.00.0-230.64.4-9.9-9.2-25.5-76.8
Cash Flow from Disc. Op. 0.00.00.00.00.00.00.00.00.00.0
Stock Based Compensation 0.00.028.336.038.443.947.366.288.2111.5
Cash Flow from Others -4.0-6.63.011.419.513.316.235.5-28.7-178.1
Cash Flow from Operations -50.1-34.5-9.287.718.718.817.6-59.6-73.5-221.7

Biomarin Pharmaceutical Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
NetIncomeFromContinuingOperations -62.0-38.1-33.57.4-69.8-67.5-82.0-90.968.6-85.1
CF_DDA -1.512.013.714.26.014.415.215.71.90.0
ChangeInWorkingCapital 12.9-26.7-16.813.314.4-102.02.110.4135.80.0
CF_DeferredTax 10.3-0.2-4.5-7.7-13.2-7.8-7.229.6-91.50.0
Cash Flow from Disc. Op. 0.00.00.00.00.00.00.00.00.00.0
Stock Based Compensation 21.717.317.520.531.223.730.730.127.10.0
Cash Flow from Others 9.59.312.2-56.36.11.428.22.3-210.085.1
Cash Flow from Operations -9.0-26.5-11.5-8.6-25.4-137.8-13.0-2.9-68.00.0
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK